Medtronic plc (MDT) stock
MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 17/303% above fair value
$102.86+1.87 (+1.85%)
Close on Nov 13, 2026Market cap $131.57BP/E 25.3Yield 2.76%
Medtronic gross margin
Gross margin is gross profit as a percentage of revenue.
Medtronic's gross margin for the twelve months ending Jul 31, 2026 was 65.0%. For fiscal 2026 it was 65.0%, against 65.3% the year before. The highest annual figure on record is 75.1% in fiscal 2013.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2026 | Apr 24, 2026 | 65.0% | −0.3 |
| FY2025 | Apr 25, 2025 | 65.3% | −0.0 |
| FY2024 | Apr 26, 2024 | 65.3% | −0.3 |
| FY2023 | Apr 28, 2023 | 65.7% | −2.3 |
| FY2022 | Apr 29, 2022 | 68.0% | +2.8 |
| FY2021 | Apr 30, 2021 | 65.2% | −2.2 |
| FY2020 | Apr 24, 2020 | 67.4% | −2.6 |
| FY2019 | Apr 26, 2019 | 70.0% | +0.3 |
| FY2018 | Apr 27, 2018 | 69.8% | +1.0 |
| FY2017 | Apr 28, 2017 | 68.7% | +0.4 |
| FY2016 | Apr 29, 2016 | 68.3% | −0.6 |
| FY2015 | Apr 24, 2015 | 68.9% | −5.7 |
| FY2014 | Apr 25, 2014 | 74.5% | −0.6 |
| FY2013 | Apr 26, 2013 | 75.1% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jul 31, 2026 | 65.0% | −0.0 |
| Q4 FY2026CQ1 2026 | Apr 24, 2026 | 65.4% | +0.6 |
| Q3 FY2026CQ4 2025 | Jan 23, 2026 | 63.8% | −2.7 |
| Q2 FY2026CQ3 2025 | Oct 24, 2025 | 65.8% | +0.9 |
| Q1 FY2026CQ2 2025 | Jul 25, 2025 | 65.0% | −0.1 |
| Q4 FY2025CQ1 2025 | Apr 25, 2025 | 64.7% | +0.2 |
| Q3 FY2025CQ4 2024 | Jan 24, 2025 | 66.5% | +0.9 |
| Q2 FY2025CQ3 2024 | Oct 25, 2024 | 64.9% | −0.5 |
| Q1 FY2025CQ2 2024 | Jul 26, 2024 | 65.1% | −0.8 |
| Q4 FY2024CQ1 2024 | Apr 26, 2024 | 64.6% | −0.6 |
| Q3 FY2024CQ4 2023 | Jan 26, 2024 | 65.6% | +0.4 |
| Q2 FY2024CQ3 2023 | Oct 27, 2023 | 65.4% | −1.2 |
| Q1 FY2024CQ2 2023 | Jul 28, 2023 | 65.9% | +0.0 |
| Q4 FY2023CQ1 2023 | Apr 28, 2023 | 65.1% | −2.8 |
| Q3 FY2023CQ4 2022 | Jan 27, 2023 | 65.2% | −3.1 |
| Q2 FY2023CQ3 2022 | Oct 28, 2022 | 66.6% | −1.6 |
| Q1 FY2023CQ2 2022 | Jul 29, 2022 | 65.9% | −1.6 |
| Q4 FY2022CQ1 2022 | Apr 29, 2022 | 68.0% | +0.4 |
| Q3 FY2022CQ4 2021 | Jan 28, 2022 | 68.3% | +2.0 |
| Q2 FY2022CQ3 2021 | Oct 29, 2021 | 68.2% | +3.6 |
| Q1 FY2022CQ2 2021 | Jul 30, 2021 | 67.5% | +6.0 |
| Q4 FY2021CQ1 2021 | Apr 30, 2021 | 67.6% | +5.3 |
| Q3 FY2021CQ4 2020 | Jan 29, 2021 | 66.3% | −2.6 |
| Q2 FY2021CQ3 2020 | Oct 30, 2020 | 64.6% | −4.3 |
| Q1 FY2021CQ2 2020 | Jul 31, 2020 | 61.5% | −6.9 |
| Q4 FY2020CQ1 2020 | Apr 24, 2020 | 62.3% | −7.3 |
| Q3 FY2020CQ4 2019 | Jan 24, 2020 | 68.9% | −1.1 |
| Q2 FY2020CQ3 2019 | Oct 25, 2019 | 68.9% | −1.6 |
| Q1 FY2020CQ2 2019 | Jul 26, 2019 | 68.4% | −1.7 |
| Q4 FY2019CQ1 2019 | Apr 26, 2019 | 69.5% | −1.0 |
| Q3 FY2019CQ4 2018 | Jan 25, 2019 | 70.0% | −0.2 |
| Q2 FY2019CQ3 2018 | Oct 26, 2018 | 70.6% | +0.7 |
| Q1 FY2019CQ2 2018 | Jul 27, 2018 | 70.2% | +2.0 |
| Q4 FY2018CQ1 2018 | Apr 27, 2018 | 70.6% | +1.3 |
| Q3 FY2018CQ4 2017 | Jan 26, 2018 | 70.2% | +1.4 |
| Q2 FY2018CQ3 2017 | Oct 27, 2017 | 69.9% | +1.6 |
| Q1 FY2018CQ2 2017 | Jul 28, 2017 | 68.2% | – |
| Q4 FY2017CQ1 2017 | Apr 28, 2017 | 69.2% | – |
| Q3 FY2017CQ4 2016 | Jan 27, 2017 | 68.9% | – |
| Q2 FY2017CQ3 2016 | Oct 28, 2016 | 68.3% | – |
See a number that looks wrong?